Osteoporosis in Active Women

References

• Consensus development conference: prophylaxis and treatment of osteoporosis. Am J Med 1991; 90(1): 107–110
   Google Scholar
• Looker AC, Johnston CC Jr, Wahner HW, et al: Prevalence of low femoral bone density in older U.S. women from NHANES III. J Bone Miner Res 1995; 10(5):796–802
   PubMed Web of Science ®Google Scholar
• Melton LJ III: How many women have osteoporosis now? J Bone Miner Res 1995; 10(2):175–177
   Google Scholar
• Owen RA, Melton IT III, Gallagher JC, et al: The national cost of acute care of hip fractures associated with osteoporosis. Clin Orthop 1980; 150(Jul-Aug): 172–176
   PubMedGoogle Scholar
• Holbrook TL: The Frequency of Occurrence, Impact and Cost of Musculoskeletal Conditions in the United States. Chicago, American Academy of Orthopedic Surgeons, 1984
   Google Scholar
• Ray WA, Griffin MR, Baugh DK: Mortality following hip fracture before and after implementation of the prospective payment system. Arch Intern Med 1990; 150(10):2109–2114
   Google Scholar
• Recker RR, Davies KM, Hinders SM, et al: Bone gain in young adult women. JAMA 1992; 268(17): 2403–2408
   PubMed Web of Science ®Google Scholar
• Birkenhager-Frenkel DH, Courpron R Hupscher A, et al: Age-related changes in cancellous bone structure: a two-dimensional study in the transiliac and iliac crest biopsy sites. Bone Miner 1988; 4(2): 197–216
   Google Scholar
• Marcus R, Kosek J, Pfefferbaum A, et al: Age-related loss of trabecular bone in premenopausal women: a biopsy study. Calcif Tissue Int 1983; 35(4–5):406–409
   Google Scholar
• Riggs BL, Wahner HW, Dann WL, et al: Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis. J Clin Invest 1981; 67(2):328–335
   PubMed Web of Science ®Google Scholar
• Mazess RB: On aging bone loss. Clin Orthop 1982; 165(May):239–252
   Google Scholar
• Drinkwater BL: Exercise in the prevention of osteoporosis, in Christiansen C, Riis B (eds): Osteoporosis Proceedings, Rodovre, Denmark, Osteopress Aps 1993, pp 105–108
   Google Scholar
• Rencken ML, Chesnut CH III, Drinkwater BL: Bone density at multiple skeletal sites in amenorrheic athletes. JAMA 1996; 276(3):238–240
   PubMed Web of Science ®Google Scholar
• The Scientific Advisory Board of the National Osteoporosis Foundation: Clinical indications for bone mass measurement. J Bone Miner Res 1989; 4 (suppl2):1–28
   Google Scholar
• Kanis JA, Melton LJ III, Christiansen C, et al: The diagnosis of osteoporosis. J Bone Miner Res 1994; 9(8): 1137–1141
   PubMed Web of Science ®Google Scholar
• American College of Sports Medicine: ACSM Position Stand on Osteoporosis and Exercise. Med Sci Sports Exerc 1995; 27(4):i-vii
   Google Scholar
• Lane NE, Block DA, Jones HH, et al: Long distance running, bone density, and osteoarthritis. JAMA 1986; 255(9):1147–1151
   PubMed Web of Science ®Google Scholar
• Michel BA, Bloch DA, Fries JF: Weight-bearing exercise, overexercise, and lumbar bone density over age 50 years. Arch Intern Med 1989; 149(10):2325–2329
   Google Scholar
• NIH consensus conference: Optimal calcium intake. JAMA 1994; 272(24): 1942–1948
   Google Scholar
• Keen AD, Drinkwater BL: No gain in vertebral bone density over 10 years in previously amenorrheic athletes, abstracted. J Bone Miner Res 1995; 10(suppl 1): S243
   PubMedGoogle Scholar
• Cumming DC: Exercise-associated amenorrhea, low bone density, and estrogen replacement therapy. Arch Intern Med 1996; 156(19):2193–2195
   Google Scholar
• Hergenroeder AC, Klish WJ, Smith EO, et al: A randomized clinical trial of bone mineral density changes in young women with hypothalamic amenorrhea treated with oral contraceptive pills. Med Sci Sports Exerc 1995; 27(5):S94
   Google Scholar
• Gulekli B, Davies MC, Jacobs HS: Effect of treatment on established osteoporosis in young women with amenorrhea. Clin Endocrinol 1994; 41(3):275–281
   PubMed Web of Science ®Google Scholar
• The Writing Group for the PEPI Trial: Effects of hormone therapy on bone mineral density: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial. JAMA 1996; 276(17):1389–1396
   Google Scholar
• Speroff L, Rowan J, Symons J, et al: The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART Study): a randomized controlled trial. JAMA 1996; 276(17): 1397–1403
   Google Scholar
• Cauley JA, Seeley DG, Ensrud K, et al: Estrogen replacement therapy and fractures in older women. Ann Intern Med 1995; 122(1):9–16
   PubMed Web of Science ®Google Scholar
• Nguyen TV; Jones G, Sambrook PN, et al: Effects of estrogen exposure and reproductive factors on bone mineral density and osteoporotic fractures. J Clin Endocrinol Metab 1995; 80(9):2709–2714
   PubMed Web of Science ®Google Scholar
• Schneider DL, Barrett-Connor EL, Morton DJ: Timing of postmenopausal estrogen for optimal bone mineral density. JAMA 1997; 277(7):543–547
   Web of Science ®Google Scholar
• Colditz GA, Hankinson SE, Hunter DJ, et al: The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995; 332(24): 1589–1593
   PubMed Web of Science ®Google Scholar
• Stanford JL, Weiss NS, Voigt LE et al: Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. JAMA 1995; 274(2):137–142
   Google Scholar
• Speroff L: Postmenopausal hormone therapy and breast cancer. Obstet Gynecol 1996; 87(2 suppl): 44S–54S
   Google Scholar
• Stampfer MJ, Colditz GA, Willett WC, et al: Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the Nurses' Health Study. N Engl J Med 1991; 325(ll):756–762
   Google Scholar
• Isenbarger DW, Chapin BL: Osteoporosis: current pharmacologic options for prevention and treatment. Postgrad Med 1997; 101(1):129–143
   Web of Science ®Google Scholar
• Grady D, Rubin SM, Petitti DB, et al: Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992; 117(12): 1016–1037
   PubMed Web of Science ®Google Scholar
• Col NF, Eckman MH, Karas RH, et al: Patient specific decisions about hormone replacement therapy in postmenopausal women. JAMA 1997; 277(14): 1140–1147
   PubMed Web of Science ®Google Scholar
• Chesnut CH III, McClung MR, Ensrud KE, et al: Alendronate treatment of the postmenopausal osteoporotic woman: effect of multiple dosages on bone mass and bone remodeling. Am J Med 1995; 99(2): 144–152
   Google Scholar
• Liberman UA, Weiss SR, Broil J, et al: Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Engl J Med 1995; 333(22): 1437–1443
   PubMed Web of Science ®Google Scholar
• Black DM, Cummings SR, Karpf DB, et al: Randomized trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 1996; 348(9041): 1535–1541
   PubMed Web of Science ®Google Scholar
• Overgaard K, Hansen MA, Jensen SB, et al: Effect of calcitonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study. BMJ 1992; 305(6853):556–561
   Google Scholar
• Kanis JA, Johnell O, Gullberg B, et al: Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture. BMJ 1992; 305(6862):1124–1128
   Google Scholar
• Reginster JY, Deroisy R, Lecart MR et al: A doubleblind, placebo-controlled, dose-finding trial of intermittent nasal salmon calcitonin for prevention of postmenopausal lumbar spine bone loss. Am J Med 1995; 98(5):452–458
   Google Scholar